August 29, 2023
As the epidemic of substance abuse continues to evolve, new challenges emerge that require public awareness and informed action. One such issue gaining traction is the appearance of the tranquilizer Xylazine, commonly known as "Tranq," in street drugs. Dr. Sid Khurana, Medical Director at Nevada Mental Health, was recently featured on ABC 13 News Las Vegas to discuss these growing concerns.
The Facts About Xylazine
- Xylazine is an animal tranquilizer meant for veterinary use, specifically for horses.
- According to police reports, this substance has contributed to at least four overdose deaths since 2020.
- Unlike fentanyl, there is no approved way to reverse a Xylazine overdose.
Expert Insight from Dr. Sid Khurana
Dr. Khurana emphasized the lack of research on the drug's effects on humans, stating, "It's not labeled or studied or researched for humans." By law, Xylazine is supposed to be sold only to veterinarians.
Risks Associated with Xylazine
The tranquilizer is now being mixed into common street drugs like heroin, cocaine, and fentanyl by dealers to increase their profits. The drug is relatively cheap, making it an appealing addition for those seeking to maximize profits at the expense of users’ health.
It has been observed that Xylazine can lower blood pressure, induce drowsiness, and decrease heart rate—effects that are particularly dangerous when combined with other substances.
A Growing Concern
Dr. Khurana’s insights align with the police warning that the number of overdose deaths could increase if nothing is done to address this issue. This adds a new layer of urgency to the fight against substance abuse and overdose deaths.
In Conclusion
As we continue to grapple with the complex issue of substance abuse, it is crucial to remain informed about emerging threats like Xylazine. Public awareness and education are the first steps towards a solution.
For more information about substance abuse treatment and mental health resources, please contact us at Nevada Mental Health.